CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
229 hedge funds and large institutions have $2.63B invested in Clovis Oncology, Inc. in 2018 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 84 increasing their positions, 80 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
30% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 40
Holders
229
Holding in Top 10
3
Calls
$86.1M
Puts
$50.8M
Top Buyers
| 1 | +$51M | |
| 2 | +$34.4M | |
| 3 | +$29.2M | |
| 4 |
AC
Armistice Capital
New York
|
+$24.7M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$19.9M |
Top Sellers
| 1 | -$89.8M | |
| 2 | -$66.2M | |
| 3 | -$45.2M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$32.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$28.7M |